Cara Mayfield | VP, Corporate Affairs
Neurogene

Cara has 20 years of experience working with biotech and life sciences companies spanning corporate, patient, product, and internal communications. Her career has encompassed leading communications and patient advocacy strategies at public life sciences companies as well as advising early-stage to commercial healthcare companies, organizations and patient groups. Cara currently serves as the Vice President of Corporate Affairs at Neurogene. Prior to Neurogene, she was Vice President of Patient Advocacy and Corporate Communications at Homology Medicines, where she led rare disease community engagement efforts, focusing on ensuring patient and caregiver needs were considered across all functions and programs. Prior to Homology, she served as Managing Director at Ten Bridge Communications, a life sciences communications consulting agency. Previously, Cara was Corporate Communications Director for OvaScience, a global fertility company, and she was a member of the Life Sciences Team at the consulting firm Feinstein Kean Healthcare (acquired by Ogilvy). She has also led public relations and internal communications efforts for a healthcare business-to-business company, worked in the corporate communications and investor relations group at Inspire Pharmaceuticals (acquired by Merck) and began her career at a boutique communications firm focused on emerging biotechnology and medical device companies. Cara holds a B.S. in Communications from Boston University.